Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print June 25, 2007, 10.1148/radiol.2442060136
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2442060136v1
244/2/337    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J. C.
Right arrow Articles by Gambhir, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J. C.
Right arrow Articles by Gambhir, S. S.
(Radiology 2007;244:337-355.)
© RSNA, 2007

Molecular Imaging Series

Cardiovascular Molecular Imaging1

Joseph C. Wu, MD, PhD, Frank M. Bengel, MD, and Sanjiv S. Gambhir, MD, PhD

1 From the Department of Medicine, Division of Cardiology (J.C.W.), Department of Radiology, Molecular Imaging Program at Stanford (J.C.W., S.S.G.), and Bio-X Program (S.S.G.), Stanford University, 300 Pasteur Dr, Edwards Bldg R354, Stanford, CA 94305-5344; and Department of Nuclear Medicine, Johns Hopkins University, Baltimore, Md (F.M.B.). Received January 25, 2006; revision requested March 24; revision received April 7; final version accepted June 1. Address correspondence to J.C.W. (e-mail: joewu{at}stanford.edu).

The goal of this review is to highlight how molecular imaging will impact the management and improved understanding of the major cardiovascular diseases that have substantial clinical impact and research interest. These topics include atherosclerosis, myocardial ischemia, myocardial viability, heart failure, gene therapy, and stem cell transplantation. Traditional methods of evaluation for these diseases will be presented first, followed by methods that incorporate conventional and molecular imaging approaches.

© RSNA, 2007




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
F. M. Bengel, T. Higuchi, M. S. Javadi, and R. Lautamaki
Cardiac positron emission tomography.
J. Am. Coll. Cardiol., June 30, 2009; 54(1): 1 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. R. Sipido, A. Tedgui, S. D. Kristensen, G. Pasterkamp, H. Schunkert, M. Wehling, P. G. Steg, W. Eisert, F. Rademakers, B. Casadei, et al.
Identifying needs and opportunities for advancing translational research in cardiovascular disease
Cardiovasc Res, June 18, 2009; (2009) cvp165v2.
[Full Text] [PDF]

Home page
 JNMHome page
F. M. Bengel
Clinical Cardiovascular Molecular Imaging
J. Nucl. Med., June 1, 2009; 50(6): 837 - 840.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]

Home page
 Circ Cardiovasc ImagingHome page
Z. A. Fayad and E. Vucic
"Feeling the RAGE" in the Atherosclerotic Vessel Wall
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 178 - 179.
[Full Text] [PDF]

Home page
 Circ Cardiovasc ImagingHome page
A. J. Sinusas, F. Bengel, M. Nahrendorf, F. H. Epstein, J. C. Wu, F. S. Villanueva, Z. A. Fayad, and R. J. Gropler
Multimodality Cardiovascular Molecular Imaging, Part I
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 244 - 256.
[Full Text] [PDF]